Literature DB >> 22709003

Synthetic 2-methoxyestradiol derivatives: structure-activity relationships.

Jean-François Peyrat1, Jean-Daniel Brion, Mouad Alami.   

Abstract

2-Methoxyestradiol (2ME2), a natural metabolite of estradiol which has no estrogenic activity, is a potent antitumor and anti-angiogenic compound, currently undergoing clinical trials for treatment of a variety of cancers. In the last two decades, an ever increasing number of synthetic 2-methoxyestradiol analogues have been reported. Structural changes include A/B/C/D-rings modification, homologation, aromatization, and introduction of various substituents on C-2 position along with substitution of alkyl and ethynyl groups for the 17-hydroxy function. In this review, an attempt has been made to compile the structure-activity relationships of various synthesized 2-methoxyestradiol analogues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22709003     DOI: 10.2174/092986712802430072

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  12 in total

Review 1.  Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.

Authors:  Kinsie E Arnst; Souvik Banerjee; Hao Chen; Shanshan Deng; Dong-Jin Hwang; Wei Li; Duane D Miller
Journal:  Med Res Rev       Date:  2019-02-11       Impact factor: 12.944

2.  Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  J Med Chem       Date:  2015-06-12       Impact factor: 7.446

3.  Assessing the regioselectivity of OleD-catalyzed glycosylation with a diverse set of acceptors.

Authors:  Maoquan Zhou; Adel Hamza; Chang-Guo Zhan; Jon S Thorson
Journal:  J Nat Prod       Date:  2013-01-29       Impact factor: 4.050

4.  A click approach to novel D-ring-substituted 16α-triazolylestrone derivatives and characterization of their antiproliferative properties.

Authors:  Judit Molnár; Éva Frank; Renáta Minorics; Zalán Kádár; Imre Ocsovszki; Bruno Schönecker; János Wölfling; István Zupkó
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

5.  DNA strand breaks induced by nuclear hijacking of neuronal NOS as an anti-cancer effect of 2-methoxyestradiol.

Authors:  Magdalena Gorska; Alicja Kuban-Jankowska; Michal Zmijewski; Antonella Marino Gammazza; Francesco Cappello; Maciej Wnuk; Monika Gorzynik; Iwona Rzeszutek; Agnieszka Daca; Anna Lewinska; Michal Wozniak
Journal:  Oncotarget       Date:  2015-06-20

6.  The in vitro effects of a novel estradiol analog on cell proliferation and morphology in human epithelial cervical carcinoma.

Authors:  Laura Susan Boyd; Devrim Gozuacik; Anna Margaretha Joubert
Journal:  Cell Mol Biol Lett       Date:  2018-03-20       Impact factor: 5.787

7.  Hypercapnia Exacerbates the Blood-Brain Barrier Disruption Via Promoting HIF-1a Nuclear Translocation in the Astrocytes of the Hippocampus: Implication in Further Cognitive Impairment in Hypoxemic Adult Rats.

Authors:  Xinqiang Liu; Hongguang Ding; Xusheng Li; Yiyu Deng; Xiaoyu Liu; Kangrong Wang; Miaoyun Wen; Shenglong Chen; Wenqiang Jiang; Hongke Zeng
Journal:  Neurochem Res       Date:  2020-04-23       Impact factor: 3.996

8.  A molecular understanding of D-homoestrone-induced G2/M cell cycle arrest in HeLa human cervical carcinoma cells.

Authors:  Renáta Minorics; Noémi Bózsity; Judit Molnár; János Wölfling; Erzsébet Mernyák; Gyula Schneider; Imre Ocsovszki; István Zupkó
Journal:  J Cell Mol Med       Date:  2015-07-31       Impact factor: 5.310

9.  Inclusion complexes of 2-methoxyestradiol with dimethylated and permethylated β-cyclodextrins: models for cyclodextrin-steroid interaction.

Authors:  Mino R Caira; Susan A Bourne; Halima Samsodien; Vincent J Smith
Journal:  Beilstein J Org Chem       Date:  2015-12-16       Impact factor: 2.883

10.  Antiproliferative Properties of Newly Synthesized 19-Nortestosterone Analogs Without Substantial Androgenic Activity.

Authors:  András Gyovai; Renáta Minorics; Anita Kiss; Erzsébet Mernyák; Gyula Schneider; András Szekeres; Erika Kerekes; Imre Ocsovszki; István Zupkó
Journal:  Front Pharmacol       Date:  2018-07-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.